ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs MXN
16.6998
0.00%
Brent Oil
81.965
0.00%
Bitcoin
69,225.00
-0.06%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Neovasc Inc (NVCN)

  7. Neovasc Inc (NVCN) Noticias

NVCN

Neovasc (NVCN)

Neovasc Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:NVCN
FechaHoraFuenteTítuloSímboloCompañía
02/08/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NVCNNeovasc Inc
24/04/202315:15Edgar (US Regulatory)Notice of Termination of a Foreign Private Issuer's Registration of a Class of Securities Under Section 12(b) (15f-12b)NASDAQ:NVCNNeovasc Inc
12/04/202312:11Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:NVCNNeovasc Inc
11/04/202308:11Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:NVCNNeovasc Inc
11/04/202308:08Edgar (US Regulatory)Post-effective Amendment to Registration Statement for Securities of Certain Canadian Issuers Under the Securities Act of 1933 (f-10pos)NASDAQ:NVCNNeovasc Inc
11/04/202308:07Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:NVCNNeovasc Inc
11/04/202308:06Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:NVCNNeovasc Inc
11/04/202307:48Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:NVCNNeovasc Inc
11/04/202307:20GlobeNewswire Inc.Shockwave Medical Completes Acquisition of NeovascNASDAQ:NVCNNeovasc Inc
31/03/202315:11GlobeNewswire Inc.Neovasc Announces Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Corporate UpdateNASDAQ:NVCNNeovasc Inc
06/03/202316:37GlobeNewswire Inc.Neovasc Shareholders Approve Acquisition by Shockwave MedicalNASDAQ:NVCNNeovasc Inc
01/02/202308:05GlobeNewswire Inc.Neovasc Announces German Reimbursement RenewalNASDAQ:NVCNNeovasc Inc
17/01/202307:00GlobeNewswire Inc.Shockwave Medical to Acquire NeovascNASDAQ:NVCNNeovasc Inc
17/01/202307:00GlobeNewswire Inc.Shockwave Medical Announces Agreement to Acquire NeovascNASDAQ:NVCNNeovasc Inc
28/11/202215:45GlobeNewswire Inc.Neovasc Announces Progress on COSIRA-II Clinical TrialNASDAQ:NVCNNeovasc Inc
18/11/202208:05GlobeNewswire Inc.Neovasc Comments on European Heart Journal PublicationNASDAQ:NVCNNeovasc Inc
15/11/202205:45TipRanksH.C. Wainwright Sticks to Its Buy Rating for Neovasc (NVCN)NASDAQ:NVCNNeovasc Inc
10/11/202215:05GlobeNewswire Inc.Neovasc Announces Third Quarter Financial Results and Provides Corporate UpdateNASDAQ:NVCNNeovasc Inc
08/11/202208:05GlobeNewswire Inc.Neovasc Reducer Obtains U.S. Outpatient ReimbursementNASDAQ:NVCNNeovasc Inc
27/10/202208:00GlobeNewswire Inc.Neovasc to Report Third Quarter Financial Results on November 10, 2022NASDAQ:NVCNNeovasc Inc
20/09/202208:05GlobeNewswire Inc.Neovasc Provides Corporate Update Following Clinical Data ReleaseNASDAQ:NVCNNeovasc Inc
16/09/202208:00GlobeNewswire Inc.Neovasc to Participate in LSI Europe 2022 Emerging MedTech SummitNASDAQ:NVCNNeovasc Inc
15/09/202208:05GlobeNewswire Inc.Neovasc Comments on New ICD-10-CM Diagnosis Codes for Refractory AnginaNASDAQ:NVCNNeovasc Inc
08/09/202208:05GlobeNewswire Inc.Neovasc Announces Key Events at TCT 2022NASDAQ:NVCNNeovasc Inc
30/08/202208:05GlobeNewswire Inc.Neovasc to Participate in H.C. Wainwright 24th Annual Global Investment ConferenceNASDAQ:NVCNNeovasc Inc
22/08/202205:20TipRanksAnalysts Offer Insights on Healthcare Companies: Freeline Therapeutics Holdings (FRLN), Cabaletta Bio (CABA) and Neovasc (NVCN)NASDAQ:NVCNNeovasc Inc
11/08/202215:05GlobeNewswire Inc.Neovasc Announces Second Quarter Financial Results and Provides Corporate UpdateNASDAQ:NVCNNeovasc Inc
28/07/202208:00GlobeNewswire Inc.Neovasc to Report Second Quarter Financial Results on August 11, 2022NASDAQ:NVCNNeovasc Inc
26/07/202208:05GlobeNewswire Inc.Neovasc Announces FDA Approval of Planned COSIRA II Sub-studies and Single Arm Registry to Allow Inclusion of Additional Specified Patient PopulationsNASDAQ:NVCNNeovasc Inc
05/07/202208:05GlobeNewswire Inc.Neovasc Announces Direct Sales Operations in United KingdomNASDAQ:NVCNNeovasc Inc
 Showing the most relevant articles for your search:NASDAQ:NVCN

Su Consulta Reciente

NASDAQ
NVDA
NVIDIA
COIN
BTCUSD
Bitcoin
AMEX
XLF
Financial Select Sector
USOTC
BNPQY
BNP Paribas (QX)
NYSE
MRK
Merck
FX
USDMXN
US Dollar vs MXN
NYSE
XOM
Exxon Mobil
USOTC
BASFY
BASF (QX)
NYSE
KO
Coca Cola
FX
EURUSD
Euro vs US Dollar
NYSE
JPM
JP Morgan Chase
CCOM
US500
US 500
AMEX
XLV
Health Care Select Sector
CCOM
US30
US 30
NYSE
AXP
American Express
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados